# Phagenesis

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/phagenesis

- Industry: Medical Devices & Equipment
- Headquarters: Manchester, UK
- Website: www.phagenesis.com
- Total disclosed funding: $59M
- Latest round: Series D (Mar 4, 2024)
- Investors on record: 6

## About

Founded in 2007 and based in Manchester, UK, Phagenesis Limited operates as a private healthcare company focused on developing treatments for dysphagia, specifically neurogenic dysphagia. In March 2024, the firm raised GBP 33.1 million in Series D funding co-led by investors EQT Life Sciences and Sectoral Asset Management, with participation from other investors British Patient Capital, Northern Gritstone, and Aphelion Capital.

The company offers Phagenyx® Neurostimulation System, this device is used for the treatment of dysphagia, a medical term for patients with difficulty in swallowing. This system features a dual-function catheter capable of both delivering stimulation and feeding, tailored to individual patient needs. The therapy aims to restore neurological control over swallowing.

The company plans to use the March 2024 funding to support its commercialization across the United States and Europe, clinical trials, regulatory activities, as well as research and development.

## Funding rounds

- Series D, Mar 4, 2024, $42M — EQT Life Sciences, Aphelion Capital, Sectoral Asset Management, British Patient Capital, Northern Gritstone
- Series B, Apr 2, 2013, $7.7M — Inventages Venture Capital
- Series B, Oct 4, 2011, $9.6M — Inventages Venture Capital

## Investors

- Inventages Venture Capital (https://capitalatlas.ai/funds/inventages-venture-capital) — Series B
- EQT Life Sciences (https://capitalatlas.ai/funds/eqt-life-sciences) — Series D
- Aphelion Capital (https://capitalatlas.ai/funds/aphelion-capital) — Series D
- Sectoral Asset Management (https://capitalatlas.ai/funds/sectoral-asset-management) — Series D
- British Patient Capital — Series D
- Northern Gritstone (https://capitalatlas.ai/funds/northern-gritstone) — Series D